-+ 0.00%
-+ 0.00%
-+ 0.00%

MediPharm Labs Receives Positive EU Regulatory Opinion for Cannabis Inhaler

PUBT·11/06/2026 00:03:35
Listen to the news
MediPharm Labs Receives Positive EU Regulatory Opinion for Cannabis Inhaler
  • MediPharm Labs received a positive regulatory opinion from BSI for its metered-dose cannabis inhaler, supporting European commercialization.
  • The opinion supports planned UK and selected European launches in 2027, subject to country-specific regulatory acceptance and import permits.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediPharm Labs Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611051900PRIMZONEFULLFEED9871953) on November 06, 2026, and is solely responsible for the information contained therein.